Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia

被引：2

作者：

Yamada, Yuji ^{[1
]}

Osumi, Tomoo ^{[1
]}

Kato, Motohiro ^{[1
]}

Shioda, Yoko ^{[1
]}

Kiyotani, Chikako ^{[1
]}

Terashima, Keita ^{[1
]}

Hayakawa, Akira ^{[2
,3
]}

Iijima-Yamashita, Yuka ^{[4
]}

Horibe, Keizo ^{[4
]}

Matsumoto, Kimikazu ^{[1
]}

Tomizawa, Daisuke ^{[1
]}

机构：

[1] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[2] Kobe Univ, Dept Pediat, Kobe, Hyogo, Japan

[3] Yodogawa Christians Hosp, Dept Palliat Med, Osaka, Japan

[4] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2022年 / 44卷 / 04期

关键词：

acute promyelocytic leukemia; relapsed; refractory; arsenic trioxide; all-trans retinoic acid; gemtuzumab ozogamicin; ACUTE MYELOID-LEUKEMIA; EVENT-FREE SURVIVAL; ARSENIC TRIOXIDE; ADOLESCENTS; EFFICACY; MYLOTARG; RELAPSE; 1ST; APL;

D O I：

10.1097/MPH.0000000000002404

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is no established treatment for patients with acute promyelocytic leukemia (APL) refractory to targeted therapies with all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). We report here a case of an 8-month-old girl with APL who failed standard ATRA-combined chemotherapy. Although molecular remission was achieved after introducing ATRA/ATO combination therapy, molecular relapse occurred during the ATO consolidation courses. Subsequent molecular remission was rapidly achieved after administering 2 doses of gemtuzumab ozogamicin. She was successfully treated with unrelated cord blood transplantation using reduced-intensity conditioning. Gemtuzumab ozogamicin might be a preferable choice for patients with APL refractory to standard therapy.

引用

页码：178 / 180

页数：3

共 50 条

[1] Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
Yamauchi, Takuji
Mori, Yasuo
Miyamoto, Toshihiro
Kamezaki, Kenjiro
Aoki, Takatoshi
Yamamoto, Asataro
Takenaka, Katsuto
Iwasaki, Hiromi
Harada, Naoki
Nagafuji, Koji
Teshima, Takanori
Akashi, Koichi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (03) : 416 - 420
[2] Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
Takuji Yamauchi
Yasuo Mori
Toshihiro Miyamoto
Kenjiro Kamezaki
Takatoshi Aoki
Asataro Yamamoto
Katsuto Takenaka
Hiromi Iwasaki
Naoki Harada
Koji Nagafuji
Takanori Teshima
Koichi Akashi
International Journal of Hematology, 2009, 90 : 416 - 420
[3] Hemorrhagic cystitis in a patient receiving gemtuzumab ozogamicin for relapsed acute promyelocytic leukemia after cord blood transplantation
Akihide Yoshimi
Takashi Asai
Akira Hangaishi
Tsuyoshi Takahashi
Shigeru Chiba
Mineo Kurokawa
Annals of Hematology, 2008, 87 : 851 - 852
[4] Successful Umbilical Cord Blood Transplantation With Reduced-intensity Conditioning for Acute Myeloid Leukemia in a Child With Shwachman-Diamond Syndrome
Yoshimura, Satoshi
Mizuno, Takanori
Osumi, Tomoo
Shioda, Yoko
Kiyotani, Chikako
Terashima, Keita
Deguchi, Takao
Nakadate, Hisaya
Kato, Motohiro
Matsumoto, Kimikazu
Tomizawa, Daisuke
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (03) : E414 - E418
[5] A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia
Zahler, Stacey
Bhatia, Monica
Ricci, Angela
Roy, Sumith
Morris, Erin
Harrison, Lauren
de Ven, Carmella van
Fabricatore, Sandra
Wolownik, Karen
Cooney-Qualter, Erin
Baxter-Lowe, Lee Ann
Luisi, Paul
Militano, Olga
Kletzel, Morris
Cairo, Mitchell S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (04) : 698 - 704
[6] Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Brunstein, Claudio G.
Eapen, Mary
Ahn, Kwang Woo
Appelbaum, Frederick R.
Ballen, Karen K.
Champlin, Richard E.
Cutler, Corey
Kan, Fangyu
Laughlin, Mary J.
Soiffer, Robert J.
Weisdorf, Daniel J.
Woolfrey, Anne
Wagner, John E.
BLOOD, 2012, 119 (23) : 5591 - 5598
[7] Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial
Rio, Bernard
Chevret, Sylvie
Vigouroux, Stephane
Chevallier, Patrice
Fuerst, Sabine
Sirvent, Anne
Bay, Jacques-Olivier
Socie, Gerard
Ceballos, Patrice
Huynh, Anne
Cornillon, Jerome
Francoise, Sylvie
Legrand, Faezeh
Yakoub-Agha, Ibrahim
Michel, Gerard
Maillard, Natacha
Margueritte, Genevieve
Maury, Sebastien
Uzunov, Madalina
Bulabois, Claude Eric
Michallet, Mauricette
Clement, Laurence
Dauriac, Charles
Bilger, Karin
Gluckman, Eliane
Ruggeri, Annalisa
Buzyn, Agnes
Nguyen, Stephanie
Simon, Tabassome
Milpied, Noeel
Rocha, Vanderson
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 445 - 453
[8] Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia
Zhou, Haixia
Zheng, Changcheng
Zhu, Xiaoyu
Tang, Baolin
Tong, Juan
Zhang, Xuhan
Zhang, Lei
Liu, Huilan
Sun, Zimin
PEDIATRIC TRANSPLANTATION, 2016, 20 (08) : 1117 - 1124
[9] Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
Azuma, Yoshiko
Nakaya, Aya
Hotta, Masaaki
Fujita, Shinya
Tsubokura, Yukie
Yoshimura, Hideaki
Satake, Atsushi
Ishii, Kazuyoshi
Ito, Tomoki
Nomura, Shosaku
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 31 - 34
[10] Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
Stein, Anthony S.
Palmer, Joycelynne M.
O'Donnell, Margaret R.
Kogut, Neil M.
Spielberger, Ricardo T.
Slovak, Marilyn L.
Tsai, Ni-Chun
Senitzer, David
Snyder, David S.
Thomas, Sandra H.
Forman, Stephen J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) : 1407 - 1414

← 1 2 3 4 5 →